These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16631742)

  • 1. Paradoxical aggregation versus oligomerisation properties of mutant and wild-type huntingtin fragments.
    Rubinsztein DC; Huntington JA
    Exp Neurol; 2006 Jun; 199(2):243-4. PubMed ID: 16631742
    [No Abstract]   [Full Text] [Related]  

  • 2. Nucleation of huntingtin aggregation in cells.
    Wetzel R
    Nat Chem Biol; 2006 Jun; 2(6):297-8. PubMed ID: 16710335
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulator of calcineurin (RCAN1-1L) is deficient in Huntington disease and protective against mutant huntingtin toxicity in vitro.
    Ermak G; Hench KJ; Chang KT; Sachdev S; Davies KJ
    J Biol Chem; 2009 May; 284(18):11845-53. PubMed ID: 19270310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward cell specificity in SCA1.
    Humbert S; Saudou F
    Neuron; 2002 May; 34(5):669-70. PubMed ID: 12062012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interacting proteins as genetic modifiers of Huntington disease.
    Li XJ; Friedman M; Li S
    Trends Genet; 2007 Nov; 23(11):531-3. PubMed ID: 17961788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodegenerative disease: neuron protection agency.
    Orr HT
    Nature; 2004 Oct; 431(7010):747-8. PubMed ID: 15483586
    [No Abstract]   [Full Text] [Related]  

  • 7. Reversing neurodegeneration: a promise unfolds.
    Orr HT; Zoghbi HY
    Cell; 2000 Mar; 101(1):1-4. PubMed ID: 10778849
    [No Abstract]   [Full Text] [Related]  

  • 8. Huntingtin contains a highly conserved nuclear export signal.
    Xia J; Lee DH; Taylor J; Vandelft M; Truant R
    Hum Mol Genet; 2003 Jun; 12(12):1393-403. PubMed ID: 12783847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 14-3-3zeta is indispensable for aggregate formation of polyglutamine-expanded huntingtin protein.
    Omi K; Hachiya NS; Tanaka M; Tokunaga K; Kaneko K
    Neurosci Lett; 2008 Jan; 431(1):45-50. PubMed ID: 18078716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clearance of mutant proteins as a therapeutic target in neurodegenerative diseases.
    Krainc D
    Arch Neurol; 2010 Apr; 67(4):388-92. PubMed ID: 20385902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of Huntington disease protein with transcriptional activator Sp1.
    Li SH; Cheng AL; Zhou H; Lam S; Rao M; Li H; Li XJ
    Mol Cell Biol; 2002 Mar; 22(5):1277-87. PubMed ID: 11839795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin.
    Bao J; Sharp AH; Wagster MV; Becher M; Schilling G; Ross CA; Dawson VL; Dawson TM
    Proc Natl Acad Sci U S A; 1996 May; 93(10):5037-42. PubMed ID: 8643525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal and mutant huntingtin: partners in crime.
    Di Prospero NA; Tagle DA
    Nat Med; 2000 Nov; 6(11):1208-9. PubMed ID: 11062523
    [No Abstract]   [Full Text] [Related]  

  • 14. Ciliogenesis is regulated by a huntingtin-HAP1-PCM1 pathway and is altered in Huntington disease.
    Keryer G; Pineda JR; Liot G; Kim J; Dietrich P; Benstaali C; Smith K; Cordelières FP; Spassky N; Ferrante RJ; Dragatsis I; Saudou F
    J Clin Invest; 2011 Nov; 121(11):4372-82. PubMed ID: 21985783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyglutamine expansion in huntingtin alters its interaction with phospholipids.
    Kegel KB; Sapp E; Alexander J; Valencia A; Reeves P; Li X; Masso N; Sobin L; Aronin N; DiFiglia M
    J Neurochem; 2009 Sep; 110(5):1585-97. PubMed ID: 19566678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducing huntingtin inclusion formation in primary neuronal cell culture and in vivo by high-capacity adenoviral vectors expressing truncated and full-length huntingtin with polyglutamine expansion.
    Huang B; Schiefer J; Sass C; Kosinski CM; Kochanek S
    J Gene Med; 2008 Mar; 10(3):269-79. PubMed ID: 18067195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GRP78 counteracts cell death and protein aggregation caused by mutant huntingtin proteins.
    Jiang Y; Lv H; Liao M; Xu X; Huang S; Tan H; Peng T; Zhang Y; Li H
    Neurosci Lett; 2012 May; 516(2):182-7. PubMed ID: 22490889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Huntingtin processing in pathogenesis of Huntington disease.
    Qin ZH; Gu ZL
    Acta Pharmacol Sin; 2004 Oct; 25(10):1243-9. PubMed ID: 15456523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Juvenile Huntington's disease: does a dosage-effect pathogenic mechanism differ from the classical adult disease?
    Squitieri F; Frati L; Ciarmiello A; Lastoria S; Quarrell O
    Mech Ageing Dev; 2006 Feb; 127(2):208-12. PubMed ID: 16274727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine enhances motor and neuropathological consequences of polyglutamine expanded huntingtin.
    Cyr M; Sotnikova TD; Gainetdinov RR; Caron MG
    FASEB J; 2006 Dec; 20(14):2541-3. PubMed ID: 17065224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.